English
This article is from Advanced Biomedical Research , volume 3 . Abstract Background:: To evaluate the efficacy and side-effects of cyclosporine-A (CsA) in improvement of consciousness and cognitive dysfunction of patients with diffuse axonal injury (DAI) after traumatic brain Materials and Methods:: This study is designed as a randomized double-blind placebo-controlled with 100 patients suffered from DAI. CsA was administered to the intervention group (n = 50) as 5 mg/kg/24 h via 250 ml dextrose water (DW) 5% solution (DW 5%) during the first 8 h after trauma. The control group (n = 50) received only DW 5% in the same course. The presenting Glasgow coma scale in addition to the Glasgow outcome scale-extended (GOS-E) and mini-mental state examination (MMSE) in the 3rd and 6th months after trauma were documented. The serum values for complete blood count (CBC), blood urea nitrogen (BUN), creatinine (Cr), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP) were checked to assess for complications. Results:: Most patients in both groups had type II DAI (46%). There was no significant difference between groups in the GOS-E scores after 3 and 6
Sign in with your free account to read, download EPUBs or listen.
Ebook · The efficacy of Cyclosporine-A on Diffuse Axonal Injury after Traumatic Brain Injury. · Aminmansour, Bahram, Fard, Salman Abbasi, Habibabadi, Majid Rezvani, Moein, Payam, Norouzi, Rasoul, Naderan, Morteza · Internet Archive